Go Pro

Pasithea Therapeutics (KTTA) Earnings Date, Estimates & Call Transcripts

Pasithea Therapeutics logo
$0.48 +0.00 (+0.52%)
Closing price 04:00 PM Eastern
Extended Trading
$0.49 +0.01 (+2.81%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pasithea Therapeutics Earnings Summary

Pasithea Therapeutics released Q2 2026 earnings on August 14, 2026, reporting an EPS of -$0.16, which met analysts' consensus estimates of -$0.16. With a trailing EPS of -$2.08, Pasithea Therapeutics' earnings are expected to decrease next year, from ($0.76) to ($1.01) per share.

Latest Q2
Earnings Date
Aug. 14Estimated
Consensus EPS
(Aug. 14)
-$0.16
Actual EPS
(Aug. 14)
-$0.16

Q2 2026 Earnings Resources

KTTA Upcoming Earnings

Pasithea Therapeutics will be holding an earnings conference call on Friday, August 14, 2026 on Friday, August 14, 2026 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Pasithea Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pasithea Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

KTTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Pasithea Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.45-$0.45-$0.45
Q2 20261-$0.16-$0.16-$0.16
Q3 20261-$0.21-$0.21-$0.21
Q4 20261-$0.24-$0.24-$0.24

Pasithea Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026-$0.16-$0.16--$0.16$0.30M-
5/15/2026Q1 2026-$0.45-$0.12+$0.33-$0.12$0.10M-
3/30/2026Q4 2025-$0.18-$0.89 -$0.71-$0.89$0.10M-
11/13/2025Q3 2025--$0.41--$0.41--
8/14/2025Q2 2025--$0.66--$0.66--
5/15/2025Q1 2025--$1.61--$1.61--
3/24/2025Q4 2024--$2.41--$2.41--

Pasithea Therapeutics Earnings - Frequently Asked Questions

Pasithea Therapeutics (NASDAQ:KTTA) last announced its quarterly earning data on Friday, August 14, 2026. Learn more on KTTA's earnings history.

In the previous quarter, Pasithea Therapeutics (NASDAQ:KTTA) reported ($0.16) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.16). Learn more on analysts' earnings estimate vs. KTTA's actual earnings.

Pasithea Therapeutics (NASDAQ:KTTA) has a recorded net income of -$20.43 million. KTTA has generated -$2.08 earnings per share over the last four quarters.

Pasithea Therapeutics' earnings are expected to decrease from ($0.76) per share to ($1.01) per share in the next year.


Earnings data for NASDAQ:KTTA is sourced from Fiscal.ai, with the most recent quarter reported on 8/14/2026. New results are added as companies report their earnings.
From Our Partners